Parker Bioscience’s UK site to see multi-million dollar investment through 2018
Parker Bioscience’s UK-based site will be expanded as part of a multi-million dollar phased investment program to be completed throughout 2018.
Archives for May 22, 2018
Evolus: US FDA validates troubled CMO site, but rejects BOTOX alternative
Evolus says its South Korean CMO has successfully addressed GMP violations, but US FDA is yet to approve the firm’s alternative to Allergan’s BOTOX.
Decreased survival in Keytruda and Tecentriq studies prompt US FDA warning
Merck & Co. and Roche have ceased enrolment in separate clinical studies trialling Keytruda and Tecentriq as single therapies, due to a lower rate of survival in patients.